N-alpha-Fmoc-N-gamma-Alloc-L-diaminobutyric acid, 98.0%, 1g

3-phenyl-N-(p-tolyl)propanamide, 95.0%, 1g

2-Bromo-4-chloro-1-(4-chlorophenyl)butan-1-one, 95.0%, 100mg

[1-(2,5-difluorophenyl)cyclopropyl]amine hydrochloride, 95.0%, 50mg

(R)-2-Aminopent-4-ynoic acid hydrochloride, 95.0%, 25g

5-Amino-3,4-dimethylisoxazole>98.0%(HPLC)(T)5g

3-Hydroxybenzaldehyde, min. 97%, for synthesis, 250 g, plastic packaging.

2-Fluoro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoic acid, 95.0%, 1g

5-(2-Nitrophenyl)isoxazole, 98%, 250mg

enoximone, 98%, 50mg

1-(2-Trifluoromethyl-phenyl)-piperidine-4-carboxylic acid, 95.0%, 1g

2,2-Difluoro-2-(pyrazin-2-yl)acetic acid, 97%, 250mg

1-([1,2,4]triazolo[4,3-a]pyridin-8-yl)ethanamine, 98%, 100mg